Jon Erling Helgestad

Medicine and Dentistry

1. Child 100%
2. Therapeutic Procedure 78%
3. Patient 62%
4. Acute Lymphoblastic Leukemia 47%
5. Thromboembolism 35%
6. Pediatrics 35%
7. Diagnosis 33%
8. Infancy 28%
9. Follow up 27%
10. Incidence 24%
11. Intrathecal Drug Administration 23%
12. Pediatric Oncology 23%
13. Pediatric Hematology 23%
14. Brain Ischemia 17%
15. Neoplasm 17%
16. Chemotherapy 15%
17. Infant 14%
18. Thrombosis 14%
19. Cancer Therapy 14%
20. Venous Thromboembolism 13%
21. Bleeding 13%
22. Sequela 13%
23. Long Term Survival 12%
24. Gamma Knife Radiosurgery 11%
25. Age 11%
26. Childhood 11%
27. Atypical Teratoid Rhabdoid Tumor 11%
28. Doxorubicin 11%
29. Allogeneic Hematopoietic Stem Cell Transplantation 11%
30. Immunosuppressive Treatment 11%
31. Rituximab 11%
32. Fever 11%
33. Minimal Residual Disease 11%
34. (3 Iodobenzyl)guanidine 11%
35. Idiopathic Thrombocytopenic Purpura 11%
36. Wilms' Tumor 11%
37. Chronic Myelogenous Leukemia 11%
38. Randomized Controlled Trial 11%
39. Ganglioneuroblastoma 11%
40. Malignant Neoplasm 11%
41. Iodine 123 11%
42. Bone Marrow Biopsy 11%
43. Computer Assisted Tomography 11%
44. Platelet 11%
45. Case Report 11%
46. Scintigraphy 11%
47. Prospective Study 11%
48. Pneumococcal Infection 11%
49. Serotype 11%
50. Vaccine 11%